Your Article Summary
Disturbed Expression of Type 1 Iodothyronine Deiodinase Splice Variants in Human Renal Cancer
Thyroid, 06/26/09
Piekielko-Witkowska A et al. - The results show that the expression and alternative splicing of DIO1 mRNA is disturbed in renal cancer, possibly due to changes in expression of splicing factors SF2/ASF and hnRNPA1.
Related Articles
A pharmacokinetic and safety study of intravenous arsenic trioxide in adult cancer patients with renal impairment
Cancer Chemotherapy and Pharmacology, 11/18/09
Relevance Score: 68%
Effect of Collecting Duct Histology on Renal Cell Cancer Outcome
The Journal of Urology, 11/18/09
Relevance Score: 68%
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Relevance Score: 68%
Incidence of Cancer in Finnish Families with Clinically Aggressive and Nonaggressive Prostate Cancer
Cancer Epidemiology, Biomarkers & Prevention, 10/27/09
Relevance Score: 67%
The Expression of Thrombospondin-1 and p53 in Clear Cell Renal Cell Carcinoma: Its Relationship to Angiogenesis, Cell Proliferation and Cancer Specific Survival
The Journal of Urology, 10/14/09
Relevance Score: 67%
Today in Basic Science/Genetics...keeping you current
Receive free subspecialty "5-minute updates" via email
A family with X-linked benign familial hematuria
Pediatric Nephrology, 12/01/09
Tacrolimus enhances transforming growth factor-[beta]1 expression and promotes tumor progression
Transplantation, 12/01/09
OCRL1 function in renal epithelial membrane traffic
American Journal of Physiology: Renal Physiology, 11/30/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Asymptomatic Advanced Pediatric Papillary Renal Cell Carcinoma Presenting as a Pulmonary Embolus
Urology, 12/02/09
Coded Tumor Size May Be Unreliable for Small Metastatic Renal Cancers in the Surveillance, Epidemiology, and End Results Dataset
Urology, 12/02/09
Factors Predicting Health-Related Quality of Life Recovery in Patients Undergoing Surgical Treatment for Renal Tumors: Prospective Evaluation Using the RAND SF-36 Health Survey
European Urology, 12/02/09

See Latest Articles